1. Home
  2. QNST vs FTRE Comparison

QNST vs FTRE Comparison

Compare QNST & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuinStreet Inc.

QNST

QuinStreet Inc.

HOLD

Current Price

$15.37

Market Cap

792.3M

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$14.77

Market Cap

864.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNST
FTRE
Founded
1999
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
792.3M
864.4M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
QNST
FTRE
Price
$15.37
$14.77
Analyst Decision
Buy
Hold
Analyst Count
5
8
Target Price
$26.40
$11.64
AVG Volume (30 Days)
549.4K
1.4M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
$1,100,345,000.00
$2,759,900,000.00
Revenue This Year
$11.18
$3.17
Revenue Next Year
$9.54
$0.04
P/E Ratio
$85.38
N/A
Revenue Growth
43.12
1.88
52 Week Low
$12.98
$3.97
52 Week High
$25.50
$25.05

Technical Indicators

Market Signals
Indicator
QNST
FTRE
Relative Strength Index (RSI) 63.73 72.68
Support Level $13.68 $12.12
Resistance Level $14.12 $13.24
Average True Range (ATR) 0.48 0.97
MACD 0.16 0.31
Stochastic Oscillator 91.52 93.39

Price Performance

Historical Comparison
QNST
FTRE

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: